Short interest in Allogene Therapeutics Inc (NASDAQ:ALLO) decreased during the last reporting period, falling from 35.05M to 31.17M. This put 20.9% of the company's publicly available shares short.

Short interest for Allogene Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Allogene Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.70M shares traded per day, it would take 11.53 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.